Princeton-based WIRB-Copernicus Group announced Thursday its Clinical Services division is acquiring PharmaSeek LLC.
The acquisition includes PharmaSeek’s wholly-owned subsidiaries PFS Clinical and PatientWise, providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites.
“At WCG, we are proud to support the members of the research ecosystem with best-of-breed solutions to optimize their participation in clinical trials,” Donald A. Deieso, executive chairman and CEO of WCG, said. “Sites are the connective tissue that unites all of the elements of clinical research; sites are where sponsors and patients come together, and where science and execution intersect. It is in the best interest of the entire research ecosystem that we help our existing sites to remain healthy and vital, and that we make research more accessible and manageable for new investigators. We are delighted to welcome PharmaSeek — an organization dedicated to increasing the efficiency, profitability and vitality of clinical research sites — to our family of companies. We look forward to expanding PharmaSeek’s presence in the market and to providing investigators, institutions and independent sites with more robust support in the management of their research.”
PharmaSeek is a provider of guidance and expertise to dedicated research sites, multispeciality practices, integrated health systems and academic medical centers that seek to expand their portfolios, profitability or management efficiency.
“We are thrilled to join WCG, and to be part of an organization so keenly focused on driving down the cost of drug development,” said Nicolas Cindric, PharmaSeek’s CEO. “It doesn’t feel like an acquisition in the traditional sense; it feels more like we’ve received an exclusive invitation to join a community of like-minded professionals who share vision for a better tomorrow. I am delighted that, through this transaction, we will be able to offer even greater value to the ecosystem we serve.”
Under the deal, PharmaSeek will continue to operate independently and retain its headquarters in Madison, Wisconsin.
Financial terms were not disclosed.